Phase III clinical trials for stem cell-based cartilage regeneration therapy have started
A group of researchers at Osaka University developed a synthetic tissue using synovium-derived mesenchymal stem cells (MSCs) for treating damaged cartilage, which had previously been incurable and had no effective therapies.
Jan 4, 2018
0
106